A Targeted Literature Review Examining Biologic Therapy Compliance and Persistence in Chronic Inflammatory Diseases to Identify the Associated Unmet Needs, Driving Factors, and Consequences

about

A Targeted Literature Review Examining Biologic Therapy Compliance and Persistence in Chronic Inflammatory Diseases to Identify the Associated Unmet Needs, Driving Factors, and Consequences

Item

http://www.wikidata.org/entity/Q58800375

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

A Targeted Literature Review E ...... ving Factors, and Consequences

@en

A Targeted Literature Review E ...... ving Factors, and Consequences

@nl

type

Item

label

A Targeted Literature Review E ...... ving Factors, and Consequences

@en

A Targeted Literature Review E ...... ving Factors, and Consequences

@nl

prefLabel

A Targeted Literature Review E ...... ving Factors, and Consequences

@en

A Targeted Literature Review E ...... ving Factors, and Consequences

@nl

P1476

A Targeted Literature Review E ...... ving Factors, and Consequences

@en

P2093

Boglarka Szegvari

http://www.w3.org/2001/XMLSchema#string

Emese Toth

http://www.w3.org/2001/XMLSchema#string

Irina Mountian

http://www.w3.org/2001/XMLSchema#string

Jeffrey R Curtis

http://www.w3.org/2001/XMLSchema#string

Maria Nassim

http://www.w3.org/2001/XMLSchema#string

Michael Schiff

http://www.w3.org/2001/XMLSchema#string

Nikos Maniadakis

http://www.w3.org/2001/XMLSchema#string

Xuan Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Targeting Medication Non-Adherence Behavior in Selected Autoimmune Diseases: A Systematic Approach to Digital Health Program Development

Off-label biologic regimens in psoriasis: a systematic review of efficacy and safety of dose escalation, reduction, and interrupted biologic therapy

Survival of TNF antagonists in spondylarthritis is better than in rheumatoid arthritis. Data from the Spanish registry BIOBADASER.

Seven-year follow-up of infliximab therapy in rheumatoid arthritis patients with severe long-standing refractory disease: attrition rate and evolution of disease activity.

Clinical efficacy of abatacept, tocilizumab, and etanercept in Japanese rheumatoid arthritis patients with inadequate response to anti-TNF monoclonal antibodies.

Impact of comorbidities on TNF inhibitor persistence in rheumatoid arthritis patients: an analysis of Korean National Health Insurance claims data.

Treatment patterns in psoriatic arthritis patients newly initiated on oral nonbiologic or biologic disease-modifying antirheumatic drugs.

Impact of body mass index on retention rates of anti-TNF-alfa drugs in daily practice for psoriasis.

Switching TNF antagonists in patients with chronic arthritis: an observational study of 488 patients over a four-year period

Impact of inadequate adherence on response to subcutaneously administered anti-tumour necrosis factor drugs: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort

P2888

s12325-018-0759-0

P304

1333-1355

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12325-018-0759-0

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30078176

http://www.w3.org/2001/XMLSchema#string

P932

6133150

http://www.w3.org/2001/XMLSchema#string